<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210617051606N8</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-02-09</date_registration>
      <primary_sponsor>Razi University</primary_sponsor>
      <public_title>Effects of exercise training and brain stimulation on drug dependency</public_title>
      <acronym></acronym>
      <scientific_title>Evaluating the Effect of Transcranial Direct Current Stimulation and Circuit Training on Drug Craving, Impulsivity, and Risky Decision-Making in Females with Drug Dependency during Rehabilitation Period</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-02-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>16</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68477</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Crossover, Purpose: Supportive, Randomization description: In this study, the order of subjects' exposure to 4 different conditions will be randomized by the Latin Squares method. To do so, first, using the www.random.org website, a number between 1 and 16 will be randomly allocated to each subject as an identification code. Then, the English letters A, B, C, and D will be assigned to the four intervention conditions and a Latin Square will be created. In this case, a Latin square with four rows and four columns is created. Finally, participants number 1 to 4 will be placed in the sequence of the first row, participants number 5 to 8 will be placed in the sequence of the second row, participants number 9 to 12 will be placed in the sequence of the third row and, participants number 13 to 16 will be placed in the sequence of the fourth row, Blinding description: In this double-blind study, the investigator and the participants will be blinded to the type of transcranial electrical stimulation used in the four experimental conditions. In the current study, the Neurostim stimulation device will be used to induce direct current electrical stimulation in two types including 1) anodal and 2) sham in four experimental conditions. For this purpose, an individual outside the research team who is thoroughly familiar with using the brain stimulation device will be responsible for applying the stimulation in experimental sessions. In order to blind the participants, after they sit on a special chair, the stimulating device is hidden from their view and is completely covered by a cover, and the electrodes are placed on the desired areas by the examiner. In order to blind the researcher, the induction of brain stimulation will be done without the presence of the researcher and the relevant information will be available to the same person outside the research team. Also, in the sham stimulation mode, according to standard protocols, the active current is induced on the head for 30 seconds to induce the same sensation as the active stimulation mode. Then the current is cut off and the stimulation is deactivated, but the electrodes will remain on the head until the end of the same time as the anodal stimulation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Drug abuse.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this study, all the subjects were exposed to three intervention conditions with an interval of at least one week in between. These conditions include 1) circuit training+ anodal stimulation of the dorsolateral prefrontal cortex, 2) circuit training+ sham stimulation, and 3) anodal stimulation of the dorsolateral prefrontal cortex. Circuit training will consist of a standard 5-7 minute warm-up followed by 4 sets of circuit training. Each set consists 8 stations including bodyweight squats, crawls, bench dips, frog jumps, sit-ups, push-ups, moving lunges, and back hyperextensions. Subjects will perform the prescribed exercise for 40 seconds at each station. Subjects will be asked to do their best in 40 seconds to perform the prescribed exercise correctly and as much as possible. There will be a 20 second rest between each station. 20 minutes with 2 milliamperes will be used to stimulate the target area in the brain. For this purpose, the Neurostim stimulation device manufactured by Medina Teb Company will be used. The target area in the brain is identified using the international brain mapping system 10-20 and the target area is stimulated using two special stimulation electrodes and a special electroencephalogram cap. In intervention conditions, the study variables will be measured before interventions, and then the subjects will receive brain stimulation and then perform the prescribed exercise. After the end of the exercise, the study variables are measured again. Intervention 2: Control group: In this study, in addition to three intervention sessions, all subjects were exposed to a control session including sham electrical brain stimulation (placebo effect). All details of the control session will be similar to the intervention sessions, except that in the control session, the brain is not electrically stimulated and the electrical current of the stimulator device will be deactivated after 30 seconds. The duration of control conditions will also be 20 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data are shared after the de-identification of the participants

When:
3 months after publication

To whom:
All individuals upon formal request

Conditions:
Data sharing requests are accepted for any purposes

Where to obtain:
To obtain any data/documents, please send an e-mail to Ehsan Amiri, a faculty member at Razi University, through the following e-mail address: e.amiri@razi.ac.ir

How to obtain:
Upon formal request, mentioning due reasons, and providing full personality details, data will be sent after 72 h via e-mail

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ehsan Amiri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 73, Faculty of Sport Sciences, Razi University, Tagh-e-Bostan, University St., Kermanshah, Iran</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6714414971</zip>
        <telephone>+98 83 3845 8428</telephone>
        <email>e.amiri@razi.ac.ir</email>
        <affiliation>Razi University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ehsan Amiri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 73, Faculty of Sport Sciences, Razi University, Tagh-e-Bostan, University St., Kermanshah, Iran</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6714414971</zip>
        <telephone>+98 83 3845 8428</telephone>
        <email>e.amiri@razi.ac.ir</email>
        <affiliation>Razi University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Aged between 18 to 50 years
Resident of Kermanshah
Not taking the drug for 2 to 12 months
Being right handed
History of drug abuse and being in the phase of rehabilitation
Absence of physical drug dependency (participating in detoxification)
Getting the certification of no prohibition of participating in the exercise training program from a specialist</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of seizures, epilepsy, or other neurological diseases
Existence of implantable devices or pacemakers in the body
Tobacco and alcohol consumption
Existence of ant musculoskeletal disorders
Participation in regular exercise training program in last 6 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z71.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Drug abuse counseling and surveillance</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this study, all the subjects were exposed to three intervention conditions with an interval of at least one week in between. These conditions include 1) circuit training+ anodal stimulation of the dorsolateral prefrontal cortex, 2) circuit training+ sham stimulation, and 3) anodal stimulation of the dorsolateral prefrontal cortex. Circuit training will consist of a standard 5-7 minute warm-up followed by 4 sets of circuit training. Each set consists 8 stations including bodyweight squats, crawls, bench dips, frog jumps, sit-ups, push-ups, moving lunges, and back hyperextensions. Subjects will perform the prescribed exercise for 40 seconds at each station. Subjects will be asked to do their best in 40 seconds to perform the prescribed exercise correctly and as much as possible. There will be a 20 second rest between each station. 20 minutes with 2 milliamperes will be used to stimulate the target area in the brain. For this purpose, the Neurostim stimulation device manufactured by Medina Teb Company will be used. The target area in the brain is identified using the international brain mapping system 10-20 and the target area is stimulated using two special stimulation electrodes and a special electroencephalogram cap. In intervention conditions, the study variables will be measured before interventions, and then the subjects will receive brain stimulation and then perform the prescribed exercise. After the end of the exercise, the study variables are measured again.</i_keyword>
      <i_keyword>Control group: In this study, in addition to three intervention sessions, all subjects were exposed to a control session including sham electrical brain stimulation (placebo effect). All details of the control session will be similar to the intervention sessions, except that in the control session, the brain is not electrically stimulated and the electrical current of the stimulator device will be deactivated after 30 seconds. The duration of control conditions will also be 20 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Changes in drug craving. Timepoint: Before and after interventions. Method of measurement: Drug craving standard questionnaire.</prim_outcome>
      <prim_outcome>Changes in impulsivity. Timepoint: Before and after interventions. Method of measurement: Go/ No Go cognitive test software.</prim_outcome>
      <prim_outcome>Risky decision-making. Timepoint: Before and after interventions. Method of measurement: IOWA gambling cognitive test software (This name is not an abbreviation and is the original name of the test).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Changes in pleasure sensation. Timepoint: Before and after interventions. Method of measurement: 11-point pleasure sensation scale.</sec_outcome>
      <sec_outcome>Changes in arousal. Timepoint: Before and after interventions. Method of measurement: 6-point felt arousal scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Razi University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-04-27</approval_date>
        <contact_name>Research Ethics Committees of Kermanshah Razi University</contact_name>
        <contact_address>Room. 73, Faculty of Sport Sciences, Razi University, University Str, Taq-e-bostan, Kermanshah, Iran Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
